PubMed · 2021 · 16 citations · 12 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntimicrobial TherapyUrinary Tract Infection PharmacotherapyUrinary Tract InfectionsAntimicrobial Resistance In Urinary Tract InfectionsEscherichia ColiMultidrug-resistant OrganismsMultidrug-resistant PathogensNovel Antibacterial AgentsUrinary Tract Infection Antibiotic TherapyUropathogenic Escherichia Coli
302. The results of the transurethral and intra-peritoneal injection of phage(s) that prepared on day 10 after the establishment of the mouse chronic model showed no effect of a single phage PEC80 in the treatment of UTI, whereas both administration routes of the phage cocktail preparation resulted in the clearance of bacteria from mice urine and homogenates of the urinary bladders and kidneys of the sacrificed mice after 24 h following the administration of phage cocktail dose. The high activity of the phage cocktail in the treatment of mouse chronic model of UTI is attributed to the broader host range of the phage cocktail, compared to the very narrow host range of the phage PEC80. It is concluded that the phage therapy by using phage preparations as the 25 phages cocktail evaluated in this study is a highly promising and potential alternative therapy for human UTIs.
12
Harry L. T. Mobley, D.M. Green, Anna L. Trifillis et al. · Infection and Immunity · 1990 · 574 citations · Full text
Prasanth Manohar, Ashok J. Tamhankar, Cecilia Stålsby Lundborg et al. · Frontiers in Microbiology · 2019 · 185 citations · Full text
Adapted Bacteriophages for Treating Urinary Tract Infections
Aleksandre Ujmajuridze, Marina Goderdzishvili, Lorenz Leitner et al. · Frontiers in Microbiology · 2018 · 159 citations · Full text
Life Sciences, Microbiology, Urology +16